论文部分内容阅读
病理生理上涉及变态反应性眼病,目前尚无理想疗法。肥大细胞稳定剂的问世,为治疗本病开辟了新途径。若应用得当,这类药物可使患者症状减轻。已有数种药物在实验中能稳定肥大细胞,但在治疗剂量时无效。至今最有希望的药物是色甘酸钠。它是目前唯一得到美国食品与药物管理局(FDA)的批准,并被广泛应用的药物。一、变态反应性眼病的生理学许多疾病可使眼部充血、搔痒、刺痛和流泪。有些眼疾,如特应性角结膜炎,严重威胁视力,应积极治疗。其它眼疾,如枯草热所致季节性变态反应性结膜炎,不影响视力,一般对眼没有威胁,但使患者感到不适。
Pathophysiology involving allergic eye disease, there is no ideal therapy. The advent of mast cell stabilizer for the treatment of this disease has opened up new avenues. If properly applied, such drugs can reduce the symptoms of patients. Several drugs have been used to stabilize mast cells in experiments, but are ineffective at therapeutic doses. The most promising drug to date is cromolyn sodium. It is currently the only drug approved by the U.S. Food and Drug Administration (FDA) and widely used. First, the physiology of allergic eye disease Many diseases can cause eye congestion, itching, stinging and tearing. Some eye diseases, such as atopic keratoconjunctivitis, a serious threat to vision, should be actively treated. Other eye diseases, such as hay fever caused by seasonal allergic conjunctivitis, does not affect vision, the general eye is no threat, but the patient feels uncomfortable.